Callie A. Scott

1.0k total citations
22 papers, 732 citations indexed

About

Callie A. Scott is a scholar working on Infectious Diseases, Virology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Callie A. Scott has authored 22 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 11 papers in Virology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Callie A. Scott's work include HIV/AIDS Research and Interventions (15 papers), HIV/AIDS drug development and treatment (12 papers) and HIV Research and Treatment (11 papers). Callie A. Scott is often cited by papers focused on HIV/AIDS Research and Interventions (15 papers), HIV/AIDS drug development and treatment (12 papers) and HIV Research and Treatment (11 papers). Callie A. Scott collaborates with scholars based in United States, Zambia and South Africa. Callie A. Scott's co-authors include Rochelle P. Walensky, Kenneth A. Freedberg, Elena Losina, Bruce R. Schackman, Paul E. Sax, Lauren M. Uhler, Bruce A. Larson, Helga Holst, Senica Chetty and Ingrid V. Bassett and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and AIDS.

In The Last Decade

Callie A. Scott

22 papers receiving 716 citations

Peers

Callie A. Scott

ID

EPIDE

VIROL

GHP

PPCH

Nonhlanhla Yende‐Zuma South Africa

Howard Moffat United States

Francis Ssali Uganda

Catherine A. Koss United States

Veronica Mulenga Zambia

Susanna Ceffa Italy

Joseph Musaazi Uganda

Anna Turkova United Kingdom

Natasha Press Canada

John Idoko Nigeria

Nonhlanhla Yende‐Zuma South Africa

Callie A. Scott

667 ×1.4

ID

444 ×1.5

EPIDE

163 ×0.8

VIROL

188 ×1.7

GHP

76 ×0.7

PPCH

Citations per year, relative to Callie A. Scott Callie A. Scott (= 1×) peers Nonhlanhla Yende‐Zuma

Countries citing papers authored by Callie A. Scott

Since Specialization

Citations

This map shows the geographic impact of Callie A. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Callie A. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Callie A. Scott more than expected).

Fields of papers citing papers by Callie A. Scott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Callie A. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Callie A. Scott. The network helps show where Callie A. Scott may publish in the future.

Co-authorship network of co-authors of Callie A. Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Callie A. Scott. A scholar is included among the top collaborators of Callie A. Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Callie A. Scott. Callie A. Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Yukich, Joshua, Callie A. Scott, Kafula Silumbe, et al.. (2020). Cost-Effectiveness of Focal Mass Drug Administration and Mass Drug Administration with Dihydroartemisinin–Piperaquine for Malaria Prevention in Southern Province, Zambia: Results of a Community-Randomized Controlled Trial. American Journal of Tropical Medicine and Hygiene. 103(2_Suppl). 46–53. 13 indexed citations

2.

Bansil, Pooja, Caterina Guinovart, Callie A. Scott, et al.. (2018). Malaria case investigation with reactive focal testing and treatment: operational feasibility and lessons learned from low and moderate transmission areas in Amhara Region, Ethiopia. Malaria Journal. 17(1). 449–449. 13 indexed citations

3.

Scott, Callie A., et al.. (2016). Mass testing and treatment for malaria in low transmission areas in Amhara Region, Ethiopia. Malaria Journal. 15(1). 305–305. 15 indexed citations

4.

Larson, Bruce A., Thandiwe Ngoma, Kafula Silumbe, et al.. (2016). A framework for evaluating the costs of malaria elimination interventions: an application to reactive case detection in Southern Province of Zambia, 2014. Malaria Journal. 15(1). 408–408. 64 indexed citations

5.

Ross, Eric L., Frank Tanser, Marie‐Louise Newell, et al.. (2014). The Impact of the 2013 WHO Antiretroviral Therapy Guidelines on the Feasibility of HIV Population Prevention Trials. HIV Clinical Trials. 15(5). 185–198. 5 indexed citations

6.

Scott, Callie A., Hari S. Iyer, Crispin Moyo, et al.. (2014). Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort study. BMC Public Health. 14(1). 296–296. 18 indexed citations

7.

Iyer, Hari S., Callie A. Scott, Gesine Meyer‐Rath, et al.. (2014). Resource Utilization and Costs of Care prior to ART Initiation for Pediatric Patients in Zambia. AIDS Research and Treatment. 2014. 1–5. 5 indexed citations

8.

Scott, Callie A., Hari S. Iyer, Maximillian Bweupe, et al.. (2013). Uptake, Outcomes, and Costs of Antenatal, Well-Baby, and Prevention of Mother-to-Child Transmission of HIV Services under Routine Care Conditions in Zambia. PLoS ONE. 8(8). e72444–e72444. 13 indexed citations

9.

Scott, Callie A., Hari S. Iyer, Gesine Meyer‐Rath, et al.. (2013). Retention in Care and Outpatient Costs for Children Receiving Antiretroviral Therapy in Zambia: A Retrospective Cohort Analysis. PLoS ONE. 8(6). e67910–e67910. 19 indexed citations

10.

Scott, Callie A., Timothy Wilkin, Paul E. Sax, et al.. (2012). Cost-effectiveness of Adding an Agent That Improves Immune Responses to Initial Antiretroviral Therapy (ART) in HIV-Infected Patients: Guidance for Drug Development. HIV Clinical Trials. 13(1). 1–10. 5 indexed citations

11.

Pho, Mai T., Soumya Swaminathan, Nagalingeswaran Kumarasamy, et al.. (2012). The Cost-Effectiveness of Tuberculosis Preventive Therapy for HIV-Infected Individuals in Southern India: A Trial-Based Analysis. PLoS ONE. 7(4). e36001–e36001. 23 indexed citations

12.

Schackman, Bruce R., Lisa R. Metsch, Grant Colfax, et al.. (2012). The cost-effectiveness of rapid HIV testing in substance abuse treatment: Results of a randomized trial. Drug and Alcohol Dependence. 128(1-2). 90–97. 27 indexed citations

13.

Scott, Callie A., Timothy Wilkin, Paul E. Sax, et al.. (2012). Cost-effectiveness of Adding an Agent That Improves Immune Responses to Initial Antiretroviral Therapy (ART) in HIV-Infected Patients: Guidance for Drug Development. HIV Clinical Trials. 13(1). 1–10. 6 indexed citations

14.

Losina, Elena, Ingrid V. Bassett, Janet Giddy, et al.. (2010). The “ART” of Linkage: Pre-Treatment Loss to Care after HIV Diagnosis at Two PEPFAR Sites in Durban, South Africa. PLoS ONE. 5(3). e9538–e9538. 162 indexed citations

15.

Walensky, Rochelle P., A. David Paltiel, Elena Losina, et al.. (2010). Test and Treat DC: Forecasting the Impact of a Comprehensive HIV Strategy in Washington DC. Clinical Infectious Diseases. 51(4). 392–400. 93 indexed citations

16.

Schroder, Kate, et al.. (2010). Meeting human resources for health staffing goals by 2018: a quantitative analysis of policy options in Zambia. Human Resources for Health. 8(1). 15–15. 22 indexed citations

17.

Bender, Melissa A., Nagalingeswaran Kumarasamy, Kenneth H. Mayer, et al.. (2009). Cost‐Effectiveness of Tenofovir as First‐Line Antiretroviral Therapy in India. Clinical Infectious Diseases. 50(3). 416–425. 49 indexed citations

18.

Schackman, Bruce R., Callie A. Scott, Rochelle P. Walensky, et al.. (2008). The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV. AIDS. 22(15). 2025–2033. 105 indexed citations

19.

Jones, Rachael, Callie A. Scott, Mark Nelson, & Jeremy Levy. (2007). Renal complications in HIV. International Journal of Clinical Practice. 61(6). 991–998. 10 indexed citations

20.

Freedberg, Kenneth A., Nagalingeswaran Kumarasamy, Elena Losina, et al.. (2007). Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy. AIDS. 21(Suppl 4). S117–S128. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact